Novozymes and Boehringer Ingelheim in probiotic partnership

© iStock/Artsanova

Novozymes and Boehringer Ingelheim Animal Health are set to collaborate on probiotic research and production in the coming years, says company VP.

The alliance will focus on developing probiotic products for use at the hatchery level, said Susanne Palsten Buchardt, VP of animal health and nutrition at Novozymes. 

The collaboration will include R&D, production, marketing and sales of a portfolio of probiotic products, said the partners.

Strong gut microflora can promote intestinal health and reduce the need for antibiotic growth promoters, they added.

“We have a number of different partnerships, and our overall strategy is partnering for impact,” Palsten Buchardt told FeedNavigator. “Boehringer Ingelheim was chosen because they are one of the leading animal health companies with strong leadership and expertise in the hatchery segment today – it was a natural choice looking at that specific part of the value chain.”

The Danish firm hopes to leverage Boehringer Ingelheim’s close relationships with large-scale producers, and gain valuable access to new distribution channels and customers looking for alternatives for antibiotic growth promoters.

The animal health company has a large share of the hatcheries worldwide, she said. “They have an existing customer base and market assess."

The alliance should allow Novozymes to solidify its position in the US market while providing more options for poultry producers there, she added.

In addition to the development work both companies will be doing, the agreement includes Novozymes’ FloraMax probiotic product, which is currently available in the US market, said Palsten Buchardt.

Boehringer Ingelheim is set to take over the sales and marketing of the product in the US and expand its reach on globally later.

The strategic collaboration has been guided by the regulatory efforts in several countries aimed at reducing the amount of antibiotics used in animal production, but was not intended as a response to particular legislation.

“This is a consequence of where the industry is trending,” she said. “Consumer demand and the regulatory [changes] support the need for our solutions to those changes.”

Investments in the probiotic space 

Novozymes has been investing in the probiotic space over the past two years.

September 2016 saw the Danish group buy German microbial research company, Organobalance, for an undisclosed sum.

Christian Munch, director, animal health and nutrition at Novozymes, told us back then:

“Organobalance has a relatively large microbial strain collection, access to such a diverse range of microorganisms will be fundamental to our core product development.

"One of the areas where we want to apply this screening technology is in our work with probiotics - the scientists at Organobalance have competencies in live microbial applications; also the R&D culture at the German firm is thoroughly science based making it, overall, a good fit for us.

He said the probiotic market is growing and that industry is looking more seriously at such microbial products in terms of “what they can and can’t do” in the context of the increasing shift away from antibiotics in animal husbandry globally.

In October 2015, Novozymes acquired US producer, Pacific Vet Group (PVG), citing its expertise in lactic acid bacteria based probiotic applications for poultry, as the rationale for the buy.

And, in May that year, it set up an R&D and marketing alliance with the Chinese owned Adisseo. That partnership launched Alterion, a probiotic for the poultry segment, on the US market in January 2016.

Related News

© istock

Chinese poultry market on Evonik's radar

Protease segment delivering for Novozymes

Protease segment delivering for Novozymes

© istock

Novozymes buys microbe screening technology to bolster probiotic work

© istock/NicoElNino

Novozymes to shed nearly 200 jobs

Novozyme-Monsanto alliance yields microbial crop boosters

Novozyme-Monsanto alliance yields microbial crop boosters

© istock/faithiecannoise

Fortune favors the brave and…Novozymes, Nestlé and Nike

DSM and Novozymes alliance targets better pig and poultry feed digestibility

DSM and Novozymes alliance targets better pig and poultry feed digestibility

There are lots of good players already in the animal probiotics market, but there is still room for innovation in the category: Novozymes

Adisseo and Novozymes align to ensure more ‘reliability’ in animal probiotic technology

© istock.com/royaltystockphoto

Adisseo rolling out new poultry probiotic worldwide, still awaiting clearance in the EU, Latin America

New application for enzyme saves gluten costs

The addition of xylanase to wheat base diets decreased digesta viscosity and fermentation, increased nutrient digestion and digesta passage, and reduced the amount of nutrients available to the microflora: study [pic: (c) istock.com Sage78]

Producer makes the case for enzymes in shift away from AGPs

Most feed enzymes are still primarily used in poultry

‘More education is required to boost feed enzyme usage rates in emerging markets’ - Freedonia

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.